| |
| |
|
| Insider
Information: |
Cooper Jeffrey H |
| Relationship: |
SVP, Chief Financial O... |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
41,089 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,641,718 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
41,089 |
|
|
| Total
Value |
$3,641,718 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
SVP, Chief Financial O... |
2012-05-14 |
41,089 |
2006-02-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
Chief Financial Officer |
• – – |
2006-02-27 |
4 |
AS |
$13.25 |
$13,250 |
D/D |
(1,000) |
0 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Financial Officer |
• – – |
2006-02-27 |
4 |
OE |
$5.15 |
$5,150 |
D/D |
1,000 |
1,000 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Financial Officer |
• – – |
2006-03-01 |
4 |
OE |
$5.15 |
$93,055 |
D/D |
15,500 |
13,500 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Financial Officer |
• – – |
2006-03-01 |
4 |
AS |
$13.25 |
$205,375 |
D/D |
(15,500) |
0 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Financial Officer |
• – – |
2006-03-16 |
4 |
AS |
$14.85 |
$185,625 |
D/D |
(12,500) |
0 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Financial Officer |
• – – |
2006-03-16 |
4 |
OE |
$8.10 |
$101,250 |
D/D |
12,500 |
12,500 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Chief Financial Officer |
• – – |
2006-08-29 |
4 |
AS |
$16.00 |
$416,000 |
D/D |
(26,000) |
0 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Chief Financial Officer |
• – – |
2006-08-29 |
4 |
OE |
$6.13 |
$198,780 |
D/D |
26,000 |
26,000 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Financial Officer |
• – – |
2006-12-06 |
4 |
AS |
$18.00 |
$261,000 |
D/D |
(14,500) |
0 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Financial Officer |
• – – |
2006-12-06 |
4 |
OE |
$8.10 |
$117,450 |
D/D |
14,500 |
14,500 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2007-08-08 |
4 |
AS |
$21.00 |
$262,500 |
D/D |
(12,500) |
0 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2007-08-08 |
4 |
OE |
$8.10 |
$101,250 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2007-08-17 |
4 |
S |
$20.12 |
$405,705 |
D/D |
(20,000) |
0 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2007-08-17 |
4 |
OE |
$5.15 |
$132,996 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2007-09-06 |
4 |
AS |
$22.50 |
$304,560 |
D/D |
(13,536) |
0 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2007-09-06 |
4 |
OE |
$8.10 |
$109,642 |
D/D |
13,536 |
13,536 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2007-09-26 |
4 |
AS |
$24.50 |
$306,250 |
D/D |
(12,500) |
0 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2007-09-26 |
4 |
OE |
$8.10 |
$101,250 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2007-10-08 |
4 |
AS |
$26.00 |
$321,880 |
D/D |
(12,380) |
0 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2007-10-08 |
4 |
OE |
$8.10 |
$100,278 |
D/D |
12,380 |
12,380 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2007-10-31 |
5 |
B |
$13.95 |
$14,019 |
D/D |
1,005 |
1,005 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2008-02-29 |
4 |
S |
$37.53 |
$1,870,362 |
D/D |
(49,720) |
6,910 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2008-02-29 |
4 |
OE |
$5.15 |
$520,873 |
D/D |
55,625 |
56,630 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2008-02-29 |
4 |
S |
$37.82 |
$224,058 |
D/D |
(5,905) |
1,005 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2008-04-30 |
4 |
B |
$13.95 |
$14,925 |
D/D |
1,070 |
2,075 |
2.74 |
- |
|
72 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
